Sign in

CIK 0001799448 · Non-accelerated filer<br>Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(800) 466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 10-Q Report Quarterly Report
  2. SC 13G Stake Amended Statement of Ownership
  3. 8-K Event Results of operations
  4. 4 Open-market buy Director bought 7,933,601 shares at $0.76 ($6,004,149)
  5. 4 Grant or award Chief Executive Officer acquired 610,277 shares (grant or award)
  6. 4 Grant or award Director acquired 183,083 shares (grant or award)
  7. 8-K Event Material agreement · Unregistered share sale
  8. 8-K Event Other events
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Delisting notice
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 8-K Event Other events
  18. 8-K Event Shareholder vote results
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 18 · 348 filings